ArticleIranian journal of pharmaceutical research : IJPR
Inhibition of Inflammatory Signals "HMGB1, NLRP3, TNF-α, IL-1β" and Oxidative Stress in Diclofenac-Induced Hepatotoxicity in Rats Using Hydroalcoholic Extract of
Article in Iranian journal of pharmaceutical research : IJPR. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Excessive and prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs) can cause hepatotoxicity. However, prevention and treatment of this complication remain challenging. Objectives: This study investigated the potential of the hydroalcoholic extract of Methods: Forty-two male Wistar rats were divided into six groups: Control group, DIC group, DIC+HEDK group in three different doses, and DIC+silymarin (SLY) group. The rats were treated for 7 days. Then, by inducing anesthesia, collecting blood from the heart, and isolating the liver, the effects of HEDK were evaluated by measuring the liver enzymes, antioxidant enzymes (using the calorimetric method), and inflammatory factors (using the RT-PCR method). Histopathological changes of the liver were also studied. Results: The DIC significantly increased the levels of enzymes in the liver, such as ALT, AST, and ALP, lipid oxidation product, malondialdehyde (MDA), and cytokines, interleukin 1 beta (IL-1β), tumor necrosis factor α (TNF-α), NOD-like receptor protein 3 (NLRP3), and high-mobility group box 1 (HMGB1). It also decreased the levels of oxidative stress factors, superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). Treatment with HEDK improved the liver's biochemical parameters and significantly reduced the inflammatory cytokines. With the reduction of MDA, antioxidant enzymes also increased. The liver's histological study showed the ameliorating effects of HEDK. Conclusions: The HEDK provided significant protection against DIC-induced toxicity due to its antioxidant effects and inhibition of inflammatory factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.